Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
GRWG GrowGeneration	$1.16 +1.8%	$1.08	$0.82 ▼ $2.70	$69.02M	3.4	582,239 shs	417,686 shs
HIMX Himax Technologies	$9.16 +3.2%	$7.73	$5.12 ▼ $13.91	$1.60B	2.16	1.87 million shs	1.56 million shs
MRNA Moderna	$26.00 -2.5%	$26.32	$23.15 ▼ $139.92	$10.06B	1.86	8.38 million shs	10.65 million shs

A Beginner's Guide to Investing in Cannabis

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
GRWG GrowGeneration	+1.75%	-12.78%	+1.75%	+5.45%	-52.07%
HIMX Himax Technologies	+3.15%	+3.74%	+10.90%	-3.17%	+38.79%
MRNA Moderna	-2.51%	-7.60%	+4.59%	-23.10%	-81.43%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
GRWG GrowGeneration	2.4532 of 5 stars	3.1	2.0	0.0	0.0	2.7	1.7	1.3
HIMX Himax Technologies	3.2248 of 5 stars	3.5	1.0	0.8	0.0	2.7	3.3	1.3
MRNA Moderna	4.5184 of 5 stars	4.0	2.0	0.0	4.6	1.9	2.5	1.3

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
GRWG GrowGeneration	2.25	Hold	$2.38	104.74% Upside
HIMX Himax Technologies	3.00	Buy	$11.90	29.91% Upside
MRNA Moderna	2.04	Hold	$46.61	79.27% Upside

Current Analyst Ratings Breakdown

Latest HIMX, GRWG, and MRNA Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
6/2/2025	MRNA Moderna	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Market Perform
5/22/2025	MRNA Moderna	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Underweight ➝ Underweight	$33.00 ➝ $26.00
5/9/2025	GRWG GrowGeneration	Lake Street Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$4.00 ➝ $2.50
5/9/2025	HIMX Himax Technologies	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Overweight	$8.80
5/2/2025	MRNA Moderna	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$78.00 ➝ $70.00
5/2/2025	MRNA Moderna	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Equal Weight ➝ Equal Weight	$45.00 ➝ $40.00
5/2/2025	MRNA Moderna	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Sector Perform ➝ Sector Perform	$32.00 ➝ $28.00
5/2/2025	MRNA Moderna	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	In-Line ➝ In-Line	$50.00 ➝ $32.00
4/17/2025	MRNA Moderna	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Market Perform
4/9/2025	MRNA Moderna	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Equal Weight ➝ Equal Weight	$39.00 ➝ $32.00
3/21/2025	MRNA Moderna	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Underweight ➝ Underweight	$40.00 ➝ $33.00

(Data available from 6/17/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
GRWG GrowGeneration	$176.68M	0.39	N/A	N/A	$2.83 per share	0.41
HIMX Himax Technologies	$914.39M	1.75	$0.48 per share	19.25	$5.13 per share	1.79
MRNA Moderna	$3.14B	3.20	N/A	N/A	$28.33 per share	0.92

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
GRWG GrowGeneration	-$46.50M	-$0.84	N/A	N/A	N/A	-26.62%	-23.73%	-17.03%	8/14/2025 (Estimated)
HIMX Himax Technologies	$79.75M	$0.49	20.36	∞	N/A	8.80%	9.09%	4.84%	8/6/2025 (Estimated)
MRNA Moderna	-$3.56B	-$8.73	N/A	N/A	N/A	-110.04%	-28.74%	-21.83%	7/30/2025 (Estimated)

Latest HIMX, GRWG, and MRNA Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
5/8/2025	Q1 2025	GRWG GrowGeneration	-$0.14	-$0.16	-$0.02	-$0.16	$39.63 million	$35.70 million
5/8/2025	Q1 2025	HIMX Himax Technologies	$0.10	$0.11	+$0.01	$0.11	$207.10 million	$215.13 million
5/1/2025	Q1 2025	MRNA Moderna	-$2.92	-$2.52	+$0.40	-$2.52	$130.35 million	$108.00 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
GRWG GrowGeneration	N/A	N/A	N/A	N/A	N/A
HIMX Himax Technologies	$0.73	7.97%	N/A	148.98%	N/A
MRNA Moderna	N/A	N/A	N/A	N/A	N/A

Latest HIMX, GRWG, and MRNA Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
5/15/2025	HIMX Himax Technologies	annual	$0.29	3.7%	6/30/2025	6/30/2025	7/11/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
GRWG GrowGeneration	N/A	5.00	3.04
HIMX Himax Technologies	0.03	1.65	1.43
MRNA Moderna	N/A	3.67	3.62

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
GRWG GrowGeneration	36.02%
HIMX Himax Technologies	69.81%
MRNA Moderna	75.33%

Insider Ownership

Company	Insider Ownership
GRWG GrowGeneration	7.62%
HIMX Himax Technologies	31.50%
MRNA Moderna	11.00%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
GRWG GrowGeneration	690	59.50 million	55.06 million	Optionable
HIMX Himax Technologies	2,100	174.91 million	119.69 million	Optionable
MRNA Moderna	3,900	386.74 million	324.40 million	Optionable

HIMX, GRWG, and MRNA Headlines

Recent News About These Companies

Moderna, Inc. (MRNA) Presents at Barclays Speaking the Science Call Series Transcript

June 16 at 5:10 PM | seekingalpha.com

Moderna (NASDAQ:MRNA) Stock Price Down 3.8% - Here's What Happened

June 16 at 4:25 PM | marketbeat.com

False claim flips facts on mRNA vaccine nerve disease risk

June 16 at 2:39 PM | aap.com.au

27,611 Shares in Moderna, Inc. (NASDAQ:MRNA) Purchased by BDF Gestion

June 16 at 7:04 AM | marketbeat.com

Moderna, Inc. (NASDAQ:MRNA) Shares Sold by SG Americas Securities LLC

June 16 at 3:48 AM | marketbeat.com

Celebrated, then disparaged: mRNA’s promise is tarnished under Trump

June 14 at 8:59 AM | msn.com

Investors Purchase High Volume of Moderna Call Options (NASDAQ:MRNA)

June 14 at 4:15 AM | marketbeat.com

Fact check: HHS misleads on mRNA vaccine safety after pulling Moderna funding

June 13, 2025 | nbcwashington.com

Here's Why Moderna (MRNA) Fell More Than Broader Market

June 13, 2025 | zacks.com

FDA Approves Expanded Indication for Moderna’s Respiratory Syncytial Virus Vaccine mRESVIA

June 13, 2025 | pharmexec.com

FDA expands approval of Moderna's RSV vaccine to some adults under age 60

June 13, 2025 | msn.com

FDA approves expanded use of Moderna’s RSV shot, but uncertainty remains

June 13, 2025 | msn.com

Moderna falls on doubts over new CDC panel's backing of RSV vaccine

June 13, 2025 | msn.com

HHS Misleads on mRNA Vaccine Safety After Pulling Moderna Funding

June 13, 2025 | msn.com

Moderna falls on fears new CDC vaccine advisory panel could cloud RSV shot prospects

June 13, 2025 | reuters.com

Moderna’s RSV Vaccine Gets FDA Nod For Younger At-Risk Adults: Retail Stays Guarded Amid RFK Jr’s Immunization Shake-Up

June 13, 2025 | msn.com

FDA expands Moderna's RSV vaccine approval to at-risk adults

June 13, 2025 | msn.com

Moderna’s mRNA RSV vaccine wins expanded FDA approval for younger adults

June 13, 2025 | pharmaceutical-technology.com

Tobam Boosts Stock Position in Moderna, Inc. (NASDAQ:MRNA)

June 13, 2025 | marketbeat.com

Moderna, Inc. (NASDAQ:MRNA) Shares Sold by Union Bancaire Privee UBP SA

June 13, 2025 | marketbeat.com

FDA clears Moderna’s RSV vaccine for use in people aged 18 to 59

June 12, 2025 | statnews.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

3 Defense Stocks That Will Profit From a Golden Dome
By Chris Markoch | May 30, 2025
View 3 Defense Stocks That Will Profit From a Golden Dome
Analysts Think These Stocks Could More Than Double in Value
By Nathan Reiff | May 23, 2025
View Analysts Think These Stocks Could More Than Double in Value
Intel’s Turnaround May Be the Best Bet No One’s Watching
By Jeffrey Neal Johnson | May 30, 2025
View Intel’s Turnaround May Be the Best Bet No One’s Watching
Bullish NVIDIA Market Set to Surge 50% Ahead of Q1 Earnings
By Thomas Hughes | May 27, 2025
View Bullish NVIDIA Market Set to Surge 50% Ahead of Q1 Earnings
Moderna Stock Looks Ripe for a Short Squeeze
By Chris Markoch | May 22, 2025
View Moderna Stock Looks Ripe for a Short Squeeze

HIMX, GRWG, and MRNA Company Descriptions

GrowGeneration NASDAQ:GRWG

$1.16 +0.02 (+1.75%)

Closing price 06/16/2025 04:00 PM Eastern

Extended Trading

$1.17 +0.01 (+0.86%)

As of 06/16/2025 07:14 PM Eastern

GrowGeneration Corp., through its subsidiaries, owns and operates retail hydroponic and organic gardening stores in the United States. The company engages in the marketing and distribution of nutrients, additives, growing media, lighting, and environmental control systems, as well as other indoor and outdoor growing products. It operates a chain of stores in California, Colorado, Michigan, Maine, Oklahoma, Oregon, Washington, Montana, New York, Ohio, Mississippi, Missouri, Arizona, Rhode Island, Florida, Massachusetts, Virginia, New Jersey, and New Mexico, as well as growgeneration.com, an online superstore for cultivators, a wholesale business for resellers, HRG Distribution, and benching, racking, and storage solutions and MMI. The company was formerly known as Easylife Corp. GrowGeneration Corp. was founded in 2008 and is based in Greenwood Village, Colorado.

Himax Technologies NASDAQ:HIMX

$9.16 +0.28 (+3.15%)

Closing price 06/16/2025 04:00 PM Eastern

Extended Trading

$9.16 +0.00 (+0.05%)

As of 04:00 AM Eastern

Himax Technologies, Inc., a fabless semiconductor company, provides display imaging processing technologies in China, Taiwan, the Philippines, Korea, Japan, Europe, and the United States. The company operates in two segments, Driver IC and Non-Driver Products. It offers display driver integrated circuits (ICs) and timing controllers that are used in televisions, PC monitors, laptops, mobile phones, tablets, automotive, ePaper devices, industrial displays, and other products. The company also provides automotive IC solutions, including traditional driver ICs; advanced in-cell touch and display driver integration; large touch and display driver integration; and local dimming timing controllers, as well as active matrix organic light-emitting diode (AMOLED) solutions, including AMOLED drivers, timing controllers, and touch controller ICs. In addition, it offers application specific IC services; liquid crystal on silicon and micro-electro mechanical system products; Power ICs; complementary metal oxide semiconductor image sensor products; wafer level optics products; 3D sensing products; and ultralow power WiseEye smart image sensing products. The company markets its display drivers to panel manufacturers, mobile device module manufacturers, and manufacturers of end-use products. Himax Technologies, Inc. was incorporated in 2001 and is headquartered in Tainan City, Taiwan.

Moderna NASDAQ:MRNA

$26.00 -0.67 (-2.51%)

Closing price 06/16/2025 04:00 PM Eastern

Extended Trading

$25.80 -0.20 (-0.75%)

As of 04:46 AM Eastern

Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, influenza, and respiratory syncytial virus, spikevax, and hMPV/PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; public health vaccines consists of Zika, Nipah, Mpox vaccines; and infectious diseases vaccines, such as lyme and norovirus vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; rare disease intracellular therapeutics; and inhaled pulmonary therapeutics. It has strategic alliances and collaborations with AstraZeneca; Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Chiesi Farmaceutici S.p.A.; Metagenomi, Inc.; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; and The Bill & Melinda Gates Foundation. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time